Current treatment for IBD mainly include anti-inflammatory drugs, immune suppressive drugs and monoclonal antibodies targeting TNF-α, IL-12, and integrin or immunosuppressive drugs. The gene discussed is TNF; the disease is inflammatory bowel disease.